The size, burden and cost of disorders of the brain in the UK

Journal of Psychopharmacology

Volumn 27, Issue 9, 2013, Pages 761-770

  Fineberg, Naomi A ^a,b,c,k   Haddad, Peter M ^d,j,k   Carpenter, Lewis ^b   Gannon, Brenda ^e   Sharpe, Rachel ^b   Young, Allan H ^f,k   Joyce, Eileen ^g   Rowe, James ^h   Wellsted, David ^b   Nutt, David J ^f,k   Sahakian, Barbara J ^i,k  

^a QUEEN ELIZABETH II HOSPITAL   (United Kingdom)

^b UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d GREATER MANCHESTER MENTAL HEALTH NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY OF LEEDS   (United Kingdom)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

^h UNIVERSITY OF CAMBRIDGE   (United Kingdom)

ⁱ UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^j UNIVERSITY OF MANCHESTER   (United Kingdom)

^k British Association for Psychopharmacology Council   (United Kingdom)

more..

Author keywords

Brain disorders; burden; cost

Indexed keywords

ADDICTION; ADOLESCENT; ADOLESCENT DISEASE; ADULT; AGED; ANXIETY DISORDER; AWARENESS; BRAIN DISEASE; BRAIN TUMOR; CEREBROVASCULAR ACCIDENT; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; COST OF ILLNESS; DEMENTIA; DISEASE ASSOCIATION; EATING DISORDER; EPILEPSY; HEADACHE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MENTAL DEFICIENCY; MOOD DISORDER; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT; PARKINSON DISEASE; PERSONALITY DISORDER; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SLEEP DISORDER; SOMATOFORM DISORDER; SYNDROME DELINEATION; SYSTEMATIC REVIEW; TRAUMATIC BRAIN INJURY; UNITED KINGDOM;

BRAIN DISORDERS; BURDEN; COST;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN; BRAIN DISEASES; CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; DELIVERY OF HEALTH CARE; GREAT BRITAIN; HEALTH CARE COSTS; HUMANS; MENTAL DISORDERS; MIDDLE AGED; PREVALENCE; YOUNG ADULT;

EID: 84883341171     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881113495118     Document Type: Review

References (65)

1. The cost of muscular dystrophy. Muscular Dystrophy Association. AccessEconomics ; 2007 :
2. A report to the Alzheimer's Society on the prevalence and economic cost of dementia in the UK produced by King's College London and London School of Economics. London: Dementia UK ; 2007 :
3. Andlin-Sobocki P, Bengt Jönsson P, Wittchen HU. Cost of disorders of the brain in Europe. Eur J Neurol. 2005 ; 12: 1-27
4. Diagnostic and statistical manual of mental disorders. 1980 ) Diagnostic and statistical manual of mental disorders (3rd ed.). Washington, DC: American Psychiatric Association. Washington, DC: American Psychiatric Association ; 1980 :
5. Diagnostic and statistical manual of mental disorders. 1987 ) Diagnostic and statistical manual of mental disorders (3rd ed., revised). Washington, DC: American Psychiatric Association. Washington, DC: American Psychiatric Association ; 1987 :
6. Diagnostic and statistical manual of mental health disorders. 1994 ) Diagnostic and statistical manual of mental health disorders (4th ed). Washington DC: American Psychiatric Association. Washington DC: American Psychiatric Association ; 1994 :
7. Balakrishnan R, Allender S, Scarborough P, et al. The burden of alcohol-related ill health in the United Kingdom. J Public Health (Oxf). 2009 ; 31: 366-373
8. Bebbington PE, Angermeyer M, Azorin JM, et al. The European Schizophrenia Cohort (EuroSC): A naturalistic prognostic and economic study. Soc Psychiatry Psychiatr Epidemiol. 2005 ; 40: 707-717
9. Blomqvist P, Lycke J, Strang P, et al. Brain tumours in Sweden 1996: Care and costs. J Neurol Neurosurg Psychiatry. 2000 ; 69: 792-798
10. Cockerell OC, Hart YM, Sander JW, et al. The cost of epilepsy in the United Kingdom: An estimation based on the results of two population-based studies. Epilepsy Res. 1994 ; 18: 249-260
11. Collins PY, Patel V, Joestl SS. Grand challenges in global mental health. Nature. 2011 ; 475 (7354). 27-30
12. Cooksey D A Review of UK Health Research Funding. London: HMSO ; 2006 :
13. Das GR, Guest JF. Annual cost of bipolar disorder to U.K. society. Br J Psychiatry. 2002 ; 180: 227-233
14. DOH (Department of Health) (2010a) Programme budgeting tools and data. National expenditure data. Available at http://webarchive.nationalarchives.gov. uk/+/www.dh.gov.uk/en/Managingyourorganisation/Financeandplanning/ programmebudgeting/dh-075743#-3 (accessed 11 July 2013).
15. DOH (Department of Health) (2010b) Progress in improving stroke care. In: Report by the comptroller and auditor general. London: The Stationery Office. Available at: http://www.nao.org.uk/wp-content/uploads/2010/02/0910291.pdf. (accessed 11 July 2013).
16. DOH (Department of Health) (2011) No health without mental health: A cross-Government mental health outcomes strategy for people of all ages. Available at: https://www.gov.uk/government/uploads/system/uploads/attachment- data/file/135434/dh-123990.pdf.pdf (accessed 12 July 2013).
17. DOH (Department of Health) (2012) Prime Minister's challenge on dementia - delivering major improvements in dementia care and research by 2015. London: Williams Lea. Available at: https://www.gov.uk/government/uploads/system/ uploads/attachment-data/file/200030/9535-TSO-2900951-PM-Challenge-Dementia- ACCESSIBLE.PDF (accessed 12 July 2013).
18. Espèrou H, Jars-Guincestre MC, Bolgert F, et al. Cost analysis of plasma-exchange therapy for the treatment of Guillain-Barre syndrome. French Cooperative Group on plasma exchange in Guillain-Barre syndrome. Intensive Care Med. 2000 ; 26: 1094-1100
19. Godet-Cayré V, Pelletier-Fleury N, Le VM, et al. Insomnia and absenteeism at work. Who pays the cost?. Sleep. 2006 ; 29: 179-184
20. Godfrey C, Stewart D, Gossop M. Economic analysis of costs and consequences of the treatment of drug misuse: 2-year outcome data from the National Treatment Outcome Research Study (NTORS). Addiction. 2004 ; 99: 697-707
21. Gustavsson A, Svensson M, Jacobi F, et al. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011a ; 21: 718-779
22. Gustavsson A, Brinck P, Bergvall N, et al. Predictors of costs of care in Alzheimer's disease: A multinational sample of 1222 patients. Alzheimers Dement. 2011b ; 7: 318-327
23. Hakkaart-van RL, Zwirs BW, Bouwmans C, et al. Societal costs and quality of life of children suffering from attention deficient hyperactivity disorder (ADHD). Eur Child Adolesc Psychiatry. 2007 ; 16: 316-326
24. Heider D, Bernert S, Konig HH, et al. Direct medical mental health care costs of schizophrenia in France, Germany and the United Kingdom - findings from the European Schizophrenia Cohort (EuroSC). Eur Psychiatry. 2009 ; 24: 216-224
25. InselTRSahakianBJVoonV. A plan for mental health. Nature483, 269 (2012). Available at: http://dx.doi.org/10.1038/483269a
26. Jacoby A, Buck D, Baker G, et al. Uptake and costs of care for epilepsy: Findings from a U.K. regional study. Epilepsia. 1998 ; 39: 776-786
27. Jacobi F, Wittchen HU, Holting C, et al. Estimating the prevalence of mental and somatic disorders in the community: Aims and methods of the German National Health Interview and Examinations Survey. Int J Method Psychiatr Res. 2002 ; 11: 1-18
28. Jennum P, Riha RL. Epidemiology of sleep apnoea/hypopnoea syndrome and sleep-disordered breathing. Eur Respir J. 2009 ; 33: 907-914
29. Jennum P, Kjellberg J. The socio-economical burden of hypersomnia. Acta Neurol Scand. 2010 ; 121: 265-270
30. Jennum P, Kjellberg J. Health, social and economical consequences of sleep-disordered breathing: A controlled national study. Thorax. 2011 ; 66: 560-566
31. Kessler RC, Aguilar-Gaxiola S, Alonso J, et al. The WHO World Mental Health (WMH) Surveys. Psychiatrie (Stuttg). 2009 ; 6: 5-9
32. Klin A, Lemish D. Mental disorders stigma in the media: Review of studies on production, content, and influences. J Health Commun. 2008 ; 13: 434-449
33. Knapp M, Romeo R, Beecham J. Economic cost of autism in the UK. Autism. 2009 ; 13: 317-336
34. Kobelt G, Berg J, Lindgren P, et al. Costs and quality of life of multiple sclerosis in the United Kingdom. Eur J Health Econ. 2006 ; 7: 96-104
35. Krauth C, Buser K, Vogel H. How high are the costs of eating disorders - anorexia nervosa and bulimia nervosa - for German society?. Eur J Health Econ. 2002 ; 3: 244-250
36. Leger D, Levy E, Paillard M. The direct costs of insomnia in France. Sleep. 1999 ; 22: 394-401
37. Linde M, Gustavsson A, Stovner LJ, et al. The cost of headache disorders in Europe: The Eurolight project. Eur J Neurol. 2012 ; 19: 703-711
38. Luengo-Fernandez R, Gray AM, Rothwell PM. Costs of stroke using patient-level data: A critical review of the literature. Stroke. 2009 ; 40: 18-23
39. Luengo-Fernandez R, Leal J, Gray AM. UK research expenditure on dementia, heart disease, stroke and cancer: are levels of spending related to disease burden?. Eur J Neurol. 2012 ; 19: 149-154
40. Mahdi-Rogers M, Kazmi M, Ferner R, et al. Autologous peripheral blood stem cell transplantation for chronic acquired demyelinating neuropathy. J Peripher Nerv Syst. 2009 ; 14: 118-124
41. McCronePDhanasiriSPatelA. (2008) Paying the price: the cost of mental health care in England to 2026. London: King's Fund. Available at: http://www.kingsfund.org.uk/sites/files/kf/Paying-the-Price-the-cost-of-mental- health-care-England-2026-McCrone-Dhanasiri-Patel-Knapp-Lawton-Smith-Kings-Fund- May-2008-0.pdf (accessed 11 July 2013).
42. McCrone P, Allcock LM, Burn DJ. Predicting the cost of Parkinson's disease. Mov Disord. 2007 ; 22: 804-812
43. Morris S, Ridley S, Lecky FE, et al. Determinants of hospital costs associated with traumatic brain injury in England and Wales. Anaesthesia. 2008 ; 63: 499-508
44. Murray CJL, Lopez AD The global burden of disease: A comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Global Burden of disease and Injury Series. Cambridge: Harvard University Press ; 1996 :
45. Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997 ; 349: 1498-1504
46. Nutt D, Goodwin G. ECNP Summit on the future of CNS drug research in Europe 2011: Report prepared for ECNP by David Nutt and Guy Goodwin. Eur Neuropsychopharmacol. 2011 ; 21: 495-499
47. Polder JJ, Meerding WJ, Bonneux L, et al. Healthcare costs of intellectual disability in the Netherlands: A cost-of-illness perspective. J Intellect Disabil Res. 2002 ; 46: 168-178
48. Polinder S, Meerding WJ, van Baar ME, et al. Cost estimation of injury-related hospital admissions in 10 European countries. J Trauma. 2005 ; 59: 1283-1290
49. Priebe S, Matanov A, Jankovic GJ, et al. Consequences of untreated posttraumatic stress disorder following war in former Yugoslavia: Morbidity, subjective quality of life and care costs. Croat M J. 2009 ; 50: 465-475
50. Priebe S, Gavrilovic JJ, Matanov A, et al. Treatment outcomes and costs at specialized centers for the treatment of PTSD after the war in former Yugoslavia. Psychiatr Serv. 2010 ; 61: 598-604
51. Prince M, Patel V, Saxena S, et al. No health without mental health. Lancet. 2007 ; 370: 859-877
52. Romeo R, Knapp M, Scott S. Economic cost of severe antisocial behaviour in children - and who pays it. Br J Psychiatry. 2006 ; 188: 547-553
53. Schepelmann K, Winter Y, Spottke AE, et al. Socioeconomic burden of amyotrophic lateral sclerosis, myasthenia gravis and facioscapulohumeral muscular dystrophy. J Neurol. 2010 ; 257: 15-23
54. Soeteman DI, Hakkaart-van RL, Verheul R, et al. The economic burden of personality disorders in mental health care. J Clin Psychiatry. 2008 ; 69: 259-265
55. Swingler RJ, Davidson DL, Roberts RC, et al. The cost of epilepsy in patients attending a specialist epilepsy service. Seizure. 1994 ; 3: 115-120
56. Thomas CM, Morris S. Cost of depression among adults in England in 2000. Br J Psychiatry. 2003 ; 183: 514-519
57. Van Asselt AD, Dirksen CD, Arntz A, et al. The cost of borderline personality disorder: Societal cost of illness in BPD-patients. Eur Psychiatry. 2007 ; 22: 354-361
58. Van Hout B, Gagnon D, Souetre E, et al. Relationship between seizure frequency and costs and quality of life of outpatients with partial epilepsy in France, Germany, and the United Kingdom. Epilepsia. 1997 ; 38: 1221-1226
59. Wasserfallen JB, Ostermann S, Leyvraz S, et al. Cost of temozolomide therapy and global care for recurrent malignant gliomas followed until death. Neuro Oncol. 2005 ; 7: 189-195
60. Wittchen HU, Jacobi F. Size and burden of mental disorders in Europe - a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol. 2005 ; 15: 357-376
61. Wittchen HU, Jacobi F, Rehm J, et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011 ; 21: 655-679
62. Wolstenholme J, Fenn P, Gray A, et al. Estimating the relationship between disease progression and cost of care in dementia. Br J Psychiatry. 2002 ; 181: 36-42
63. The ICD-10 classification of mental and behavioural disorders: Diagnostic criteria for research. World Health Organization ; 1993 :
64. WHO (World Health Organization) (2002) The World Health Report 2002 - reducing risks, promoting healthy life. Available at: http://www.who.int/whr/ 2002/en/whr02-en.pdf (accessed 12 July 2013).
65. WHO (World Health Organization) (2008) The Global burden of disease 2004 Update. Available at: http://www.who.int/healthinfo/global-burden-disease/GBD- report-2004update-full.pdf (accessed 11 July 2011).